Related Experiment Video
Updated: May 31, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Different therapeutic responses in chronic obstructive pulmonary disease subgroups
1Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Seoul, South Korea.
Summary
Chronic obstructive pulmonary disease (COPD) subgroups classified by diffusing capacity of the lung for carbon monoxide (DL(CO)) and lung volume show varied responses to bronchodilators and inhaled corticosteroids. This highlights the need for personalized COPD treatment strategies.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) is a heterogeneous respiratory condition.
- Accurate classification of COPD patient subgroups is crucial for optimizing treatment efficacy.
- Lung function parameters like diffusing capacity of the lung for carbon monoxide (DL(CO)) and lung volumes (RV/TLC ratio) can aid in subgroup identification.
Purpose of the Study:
- To investigate the differential therapeutic responses in chronic obstructive pulmonary disease (COPD) subgroups.
- To classify COPD patients based on baseline DL(CO) and residual volume/total lung capacity (RV/TLC) ratio.
- To compare treatment responses to short-acting β(2)-agonist (SABA) and a combination of long-acting β(2)-agonist (LABA) and corticosteroid.
Main Methods:
- A cohort of 130 stable male COPD patients from eleven South Korean hospitals were analyzed.
- Patients were categorized into four subgroups based on DL(CO) and RV/TLC ratio.
- Therapeutic responses to SABA and a 3-month LABA/corticosteroid regimen were assessed for each subgroup.
Main Results:
- The subgroup with normal DL(CO) and a high RV/TLC ratio demonstrated significantly greater flow and volume responses to salbutamol compared to those with normal DL(CO) and normal RV/TLC.
- This same subgroup (normal DL(CO)/high RV/TLC) also exhibited superior flow and volume responses to the 3-month LABA/corticosteroid treatment compared to subgroups with normal RV/TLC.
- The distribution of patients across the four subgroups (normal/normal, low/normal, normal/high, low/high DL(CO)/RV/TLC) was detailed.
Conclusions:
- COPD patient subgroups, defined by DL(CO) and RV/TLC, exhibit distinct pulmonary function responses to pharmacological interventions.
- These findings suggest that DL(CO) and RV/TLC are valuable parameters for stratifying COPD patients for targeted therapy.
- Personalized treatment approaches based on these physiological markers may enhance therapeutic outcomes in COPD management.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...